ÂÜÀòÂÒÂ×

Pearl joined Proteomics International in 2013, and is now responsible for managing the product development and commercialisation of PromarkerD, the company’s predictive diagnostic test for diabetic kidney disease.

Pearl has a background in Research, focusing on Biochemistry and Molecular Biology. She dedicated her career to the biotechnology industry following her involvement in an Industry-Research Collaboration (Researchers in Business Grant) between Proteomics International and UWA, to commercialise a patented technology for measuring oxidative stress.